M
Mona Saraiya
Researcher at Centers for Disease Control and Prevention
Publications - 258
Citations - 18861
Mona Saraiya is an academic researcher from Centers for Disease Control and Prevention. The author has contributed to research in topics: Cervical cancer & Population. The author has an hindex of 57, co-authored 247 publications receiving 15391 citations. Previous affiliations of Mona Saraiya include American Society for Clinical Pathology.
Papers
More filters
Journal ArticleDOI
Economic analysis of the Nairobi Cancer Registry: Implications for expanding and enhancing cancer registration in Kenya
Anne Korir,Robai Gakunga,Sujha Subramanian,Nathan Okerosi,Gladys C. Chesumbai,Patrick Edwards,Florence K. L. Tangka,Rachael Joseph,Nathan Buziba,Victor Rono,Donald Maxwell Parkin,Mona Saraiya +11 more
TL;DR: Evaluating the funding, cost, and labor resources used to perform the cancer registry operations in Nairobi County for two annual periods between July 2012 and June 2014 found stable funding is necessary to sustain core registry activities in other to deliver high-quality data, which in turn is needed to foster evidence-based policies to improve cancer outcomes.
Journal ArticleDOI
Opting out of cervical cancer screening: physicians who do not perform pap tests.
TL;DR: The perception that patients benefit from cervical cancer screening administered by gynecologists may deter screening in primary care settings, resulting in missed opportunities to offer screening to women who are never or rarely screened.
Book ChapterDOI
Impact of intervention strategies to reduce UVR exposure
TL;DR: It has been well documented in this book and elsewhere that skin cancer is a significant and, in many parts of the world, growing health problem (see Chapters 1 and 5).
Journal ArticleDOI
Assessing Cervical Cancer Screening Coverage Using a Population-Based Behavioral Risk Factor Survey--Thailand, 2010.
Rachael Joseph,Supawan Manosoontorn,Nawarat Petcharoen,Suleeporn Sangrajrang,Virginia Senkomago,Mona Saraiya +5 more
TL;DR: Although the national cervical cancer screening program in Thailand appears to be close to reaching its national targets, the causes of lower coverage in some subpopulations need to be identified so that targeted interventions can be developed to increase coverage in these groups.
Journal ArticleDOI
Perceived effectiveness of HPV test as a primary screening modality among US providers
TL;DR: Significant agreement that the HPV test administered alone is an effective cervical cancer screening modality was widespread among providers in both 2009 and 2012, however implementation of guidelines for screening with the HPV Test may be influenced by many other factors including reimbursement and patient preferences.